VX-702
Product Specifications
CAS Number
745833-23-2
Target
Autophagy, p38 MAPK
Related Pathways
Autophagy, MAPK
Purity
>99.99%
Bioactivity
VX-702 is a highly specific p38α MAPK inhibitor, 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA) .
Smiles
NC(=O)N(c1ccc(C(N)=O)c(n1)-c1ccc(F)cc1F)c1c(F)cccc1F
Molecular Formula
C19H12F4N4O2
Molecular Weight
404.32
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6144687-01 0.1 mL
SVIL (Supervillin, Archvillin, p205/p250, DKFZp686A17191) (Biotin)
Sign In for Pricing
View Details MBS6144687-02 5x 0.1 mL
SVIL (Supervillin, Archvillin, p205/p250, DKFZp686A17191) (Biotin)
Sign In for Pricing
View Details 
K2740504 1.0 µg DNA
ZPLD1 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details